Note 13: INCENTIVE STOCK COMPENSATION PLANSAs of November 30, 2006, the Company had outstanding grants
under the following share-based compensation plans:
- 1994 Non-Employee Director Stock Option Plan ("1994 Plan")
- The 1994 Plan was terminated in 2001, except as to the
outstanding options. A total of 240,000 new shares of
common stock were made available for awards to nonemployee
directors. Non-employee directors were granted
options to purchase the Company's common stock at prices
not less than 100% of market value on the date of grant. Such
options vested in equal annual installments over four years
and terminate ten years from the dates of grant.
- 2001 Stock Incentive Plan ("2001 Plan") - The 2001 Plan was
terminated in 2004, except as to the outstanding stock
options and restricted stock grants. A total of 380,000 new
shares of common stock were made available for awards to
key employees and non-employee directors. The 2001 Plan
served as the successor to the 1994 Plan and superseded that
plan. Non-employee directors were granted options under
the 2001 Plan to purchase the Company's common stock at
prices not less than 100% of market value on the date of
grant. Such options vested in equal annual installments over
four years. Such options terminate ten years from the date of
grant. Key employees were granted restricted stock under the
2001 Plan. Such restricted stock grants vested in equal
annual installments over four years.
- 2004 Stock Incentive Plan ("2004 Plan") - The 2004 Plan
serves as the successor to the 2001 Plan and supersedes that
plan. A total of 525,000 new shares of common stock were
made available for awards to key employees and nonemployee
directors and may include, but are not limited to,
stock options and restricted stock grants. Non-employee
directors were granted options under the 2004 Plan to
purchase the Company's common stock at prices not less
than 100% of market value on the date of grant. Such options
vest in equal annual installments over four years and
terminate ten years from the date of grant. Key employees
were granted restricted stock under the 2004 Plan. Such
restricted stock grants vest in equal annual installments over
three years. During the twelve months ended November 30,
2006, the Company granted 45,000 restricted shares to key
employees with fair value of $2,461,000 and 6,000 restricted
shares to non-employee directors with fair value of $360,000.
In addition to the above, on January 24, 2001, non-employee
directors were granted options to purchase the Company's
common stock at prices not less than 100% of market value on the
dates of grant. Such options vested in equal annual installments
over four years and terminate ten years from the dates of grant. At
November 30, 2006, there were 24,000 shares subject to such stock
options.
Prior to December 1, 2005, the Company applied Accounting
Principles Board Opinion No. 25, "Accounting for Stock Issued to
Employees", and related interpretations in accounting for its
various stock option plans. Effective December 1, 2005, the
Company adopted SFAS No. 123 (revised 2004), "Share-Based
Payments", using the Modified Prospective Application method.
SFAS No. 123 (R) requires the Company to measure all employee
stock-based compensation awards using the fair-value method
and to record such expense in its consolidated financial
statements. Under the Modified Prospective Application method,
financial results for the prior periods have not been adjusted.
Stock-based compensation expense for the year ended November
30, 2006 includes: (a) compensation expense for all stock-based
compensation awards granted prior to, but not yet vested, as of
December 1, 2005, based on the grant-date fair value estimated in
accordance with the original provisions of SFAS No. 123,
"Accounting for Stock-Based Compensation", and (b)
compensation expense for all stock-based compensation awards
granted subsequent to November 30, 2005, based on the grantdate
fair value estimated in accordance with the provisions of
SFAS No. 123 (R).
As a result of adopting SFAS No. 123 (R), the Company's income
from continuing operations before income taxes and equity in
earnings of joint venture for the year ended November 30, 2006
included compensation expense of $111,000, net of taxes of
$40,000, related to stock-based compensation arrangements. This
amount reduced basic earnings per share and diluted earnings per
share from continuing operations by $.01 for the year ended
November 30, 2006. There were no capitalized share-based
compensation costs for the year ended November 30, 2006.
Prior to the adoption of SFAS No. 123 (R), the Company reported
all tax benefits resulting from the exercise of stock options as
operating cash flows in its consolidated statements of cash flows.
In accordance with SFAS No. 123 (R), the Company will present
excess tax benefits from the exercise of stock options as financing
cash flows. For the year ended November 30, 2006, excess tax
benefits totaled $2,469,000.
The following table illustrates the effect on net income and
earnings per share as if the Company had applied the fair value
recognition provisions of SFAS No. 123 to stock-based
compensation for the year ended November 30:
| (In thousands except per share data) |
2005 |
2004 |
| Reported net income |
$32,610 |
$13,459 |
Add: Stock-based employee
compensation expense
included in reported net income,
net of tax |
1,645 |
1,149 |
Deduct: Stock-based employee
compensation
expense determined under SFAS No.123, net of tax |
(1,212) |
(889) |
| |
|
| Pro forma net income |
$33,043 |
$13,719 |
| |
|
| Earning per share (basic) |
|
|
| As reported |
$ 3.88 |
$ 1.63 |
| Pro forma |
3.93 |
1.66 |
Earning per share (diluted)
|
|
|
| As reported |
3.80 |
1.59 |
| Pro forma |
3.85 |
1.62 |
The following summarizes information about stock options outstanding as of November 30, 2006:
Current Year Stock-Based Compensation
| (in thousands) |
Number of Options |
Weighted
Average
Exercise Price |
Weighted Average Remaining
Contractual Life
(in years) |
Aggregate Intrinsic-Value
(in thousands) |
|
Outstanding at
November 30, 2005 |
467,783 |
24.11 |
|
|
| Exercised |
(347,283) |
23.02 |
29.70 |
$20.16 |
| |
|
|
|
|
Outstanding at
November 30, 2006 |
120,500 |
27.25 |
4.93 |
$ 5,779 |
| |
|
|
|
|
Options exercisable at
November 30, 2006 |
98,000 |
26.01 |
4.30 |
$4,821 |
| |
|
|
|
|
For the fiscal year ended November 30, 2006, no options were granted,
forfeited or expired. The aggregate intrinsic value in the table above
represents the total pretax intrinsic value, which is the difference
between the Company's closing stock price on the last trading day of
fiscal 2006 and the exercise price times the number of shares that
would have been received by the option holders if they had exercised
their options on November 30, 2006. This amount will change based
on the fair market value of the Company's stock. The aggregate
intrinsic value of stock options exercised for the years ended
November 30, 2006, 2005 and 2004 was $13,870,000, $4,781,000 and
$2,481,000, respectively. As of November 30, 2006, there was
$1,952,000 of total unrecognized compensation cost related to stockbased
compensation arrangements. That cost is expected to be
recognized over a weighted-average period of 2.5 years.
For the years ended November 30, 2006, 2005 and 2004, 51,000,
42,500 and 56,000 shares of restricted stock were granted,
respectively. The weighted-average grant-date fair value of such
restricted stock was $55.31, $36.20 and $34.50, respectively. The fair
value of restricted stock vested for the years ended November 30,
2006, 2005 and 2004 was $3,973,000, $1,738,000 and $760,000,
respectively.
Net cash proceeds from stock option exercises for the years ended
November 30, 2006, 2005 and 2004 was $7,994,000, $5,300,000 and
$3,315,000, respectively. The Company's policy is to issue shares from
its authorized shares upon the exercise of stock options.
|